R&D Partner Content The Future of DDR-Targeted Oncology Starts Here! 9th DDR Inhibitors Summit | January 27–29, 2026 | Boston, MA
R&D Partner Content The Future of Patient-Centric Access is Here! 6th Operationalize: Expanded Access Programs Summit | March 24-26, 2026 | Boston, MA
R&D Partner Content 7th Annual AI in Drug Discovery Conference The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place in March 2026
R&D Partner Content 6th Age-Related Disease Therapeutics Summit Translating Aging Science into a Clinical Reality
R&D Partner Content 7th CNS Drug Delivery Summit Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
R&D Partner Content Innovating Disease-Modifying Neurodegenerative Therapies to ... Discovering, Translating & Clinically Advancing Novel Targets
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
